MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
Francesca Fanini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Muller Fabbri(The University of Texas MD Anderson Cancer Center)
Cited by 13